- Home
- HBANL vs XGN Comparison
HBANL vs XGN Comparison
Compare HBANL & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HBANL
Huntington Bancshares Incorporated Depositary Shares Each Representing a 1/40th Interest in a Share of 6.875% Series J Non-Cumulative Perpetual Preferred Stock
Current Price
Company Overview
Basic Information| Metric | HBANL | XGN |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | 20242 | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 138.0M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | HBANL | XGN |
|---|---|---|
| Price | $25.48 | $5.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $13.67 |
| AVG Volume (30 Days) | N/A | ★ 321.5K |
| Earning Date | N/A | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $63,599,000.00 |
| Revenue This Year | N/A | $21.76 |
| Revenue Next Year | N/A | $15.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.08 |
| 52 Week Low | N/A | $2.67 |
| 52 Week High | N/A | $12.23 |
Technical Indicators
Market Signals| Indicator | HBANL | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 43.26 | 29.08 |
| Support Level | $25.24 | $5.74 |
| Resistance Level | $25.50 | $6.21 |
| Average True Range (ATR) | 0.22 | 0.33 |
| MACD | -0.03 | 0.07 |
| Stochastic Oscillator | 32.56 | 23.26 |
Price Performance
Historical ComparisonAbout HBANL Huntington Bancshares Incorporated Depositary Shares Each Representing a 1/40th Interest in a Share of 6.875% Series J Non-Cumulative Perpetual Preferred Stock
Huntington is a regional US bank with around $208 billion in assets and has a large presence, particularly in the Midwestern market. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.